Treatment‐related adverse effects · men with chronic (≥ 12 months) Peyronie's disease (single plaque)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐related adverse effects · men with chronic Peyronie's disease (plaques without calcification)
It is very uncertain whether injectional nicardipine changes treatment‐related adverse effects compared with saline (very low certainty).
1 finding from 1 review
Treatment‐related adverse effects · men with Peyronie's disease (diagnosis of disease: at least 12 months, penile curvature: at least 30 degrees)
The review found no eligible studies for this question.
2 findings from 1 review
Treatment‐related adverse effects · men with acute (maximum of 12 months) Peyronie's disease with no prior treatment and no evidence of calcified plaques (pain during…
It is very uncertain whether potassium paraaminobenzoate changes treatment‐related adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Treatment‐related adverse effects · men with Peyronie's disease (palpable plaque or pain)
1 finding from 1 review
Treatment‐related adverse effects · men with Peyronie's disease (stable phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐related adverse effects · men with Peyronie's disease (palpable plaque or pain)
It is very uncertain whether extracorporeal shock wave treatment (ESWT) changes treatment‐related adverse effects compared with sham (very low certainty).
1 finding from 1 review
Treatment‐related adverse effects · men with Peyronie's disease (diagnosis of disease: varying, penile curvature: at least 30 degrees)
1 finding from 1 review
Treatment‐related adverse effects (long‐term) · men with Peyronie's disease (not defined)
1 finding from 1 review